A randomised phase I study of etrolizumab (rhuMAb β7) in moderate to severe ulcerative colitisPaul Rutgeerts, Sharon O’Byrne, Richard N. Fedorak et al.|Gut|2012Cited by 151
A Phase I Study of rHuMab Beta7 in Moderate to Severe Ulcerative Colitis (UC)Paul Rutgeerts, Sharon O’Byrne, Diana Luca et al.|Gastroenterology|2011Cited by 9
A Phase 1/2 first-in-human study to evaluate the safety, tolerability, and pharmacokinetics of UX053 in patients with glycogen storage disease type IIIDavid Rodriguez‐Buritica, Andrew Grimm, Diana Luca et al.|Molecular Genetics and Metabolism|2024Cited by 0